COVID-19 vaccine for emergency use after an advisory panel voted in favor of it. «Following yesterday's positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the U.S.
Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization,» FDA Commissioner Stephen Hahn and Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said in a statement.«The agency has also notified the U.S.
Centers for Disease Control and Prevention and Operation Warp Speed, so they can execute their plans for timely vaccine distribution,» they said.An expert panel voted Thursday 17 to 4 in favor of recommending the drug for.